PEAK6’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-12,000
Closed -$2.28K – 3292
2024
Q3
$2.28K Sell
12,000
-6,000
-33% -$1.24K ﹤0.01% 3305
2024
Q2
$3.64K Sell
18,000
-7,000
-28% -$1.66K ﹤0.01% 3361
2024
Q1
$6.25K Hold
25,000
– – ﹤0.01% 3774
2023
Q4
$4.82K Hold
25,000
– – ﹤0.01% 3976
2023
Q3
$6.32K Hold
25,000
– – ﹤0.01% 3842
2023
Q2
$9.9K Hold
25,000
– – ﹤0.01% 3642
2023
Q1
$7K Hold
25,000
– – ﹤0.01% 3988
2022
Q4
$6.25K Hold
25,000
– – ﹤0.01% 4112
2022
Q3
$11K Hold
25,000
– – ﹤0.01% 4588
2022
Q2
$9.9K Hold
25,000
– – ﹤0.01% 3643
2022
Q1
$15K Buy
+25,000
New +$13.6K ﹤0.01% 4761

Other funds holding DRTSW

PEAK6's DRTSW Position: Q4 2024 in Review

PEAK6 sold out of Alpha Tau Medical Warrant (DRTSW) in Q4 2024, closing a stake of 12,000 shares — an estimated $2.28K sold.

PEAK6 first reported a position in DRTSW in Q1 2022 and held it in 11 quarters. The position peaked at $15K in Q1 2022. 26 funds tracked by Wall St. Rank hold DRTSW as of Q4 2024.

  • PEAK6 reported no remaining Alpha Tau Medical Warrant position as of Q4 2024 after selling out during the quarter.
  • PEAK6 sold 12,000 Alpha Tau Medical Warrant shares in Q4 2024, an estimated $2.28K.
  • PEAK6 first reported a position in Alpha Tau Medical Warrant in Q1 2022 and held it in 11 quarters.
  • PEAK6's Alpha Tau Medical Warrant position peaked at $15K in Q1 2022.
  • 26 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q4 2024.

Based on PEAK6's 13F filing for Q4 2024, filed 13 Feb 2025.